Human bone chips release of sclerostin and FGF-23 into the culture medium: An in vitro pilot study

Clinical Oral Implants Research

Volumn 26, Issue 10, 2015, Pages 1211-1214

  Brolese, Eliane ^a,b   Buser, Daniel ^b   Kuchler, Ulrike ^b   Schaller, Benoit ^a   Gruber, Reinhard ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Autologous bone; Bone grafts; Demineralized bone matrix; FGF 23; Osteocytes; Sclerostin

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CULTURE MEDIUM; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; GENETIC MARKER; SOST PROTEIN, HUMAN;

ADULT; AGED; CELL CULTURE TECHNIQUE; CHEMISTRY; CULTURE MEDIUM; FEMALE; GENETIC MARKER; HUMAN; MALE; METABOLISM; MIDDLE AGED; OSTEOCYTE; PILOT STUDY; YOUNG ADULT;

ADULT; AGED; BONE MORPHOGENETIC PROTEINS; CELL CULTURE TECHNIQUES; CULTURE MEDIA; FEMALE; FIBROBLAST GROWTH FACTORS; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; OSTEOCYTES; PILOT PROJECTS; YOUNG ADULT;

EID: 84940961270     PISSN: 09057161     EISSN: 16000501     Source Type: Journal    
DOI: 10.1111/clr.12432     Document Type: Article

References (24)

1. van Bezooijen, R.L., Roelen, B.A., Visser, A., van der Wee-Pals, L., de Wilt, E., Karperien, M., Hamersma, H., Papapoulos, S.E., ten Dijke, P. & Lowik, C.W. (2004) Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical bmp antagonist. Journal of Experimental Medicine 199: 805-814
2. Bonewald, L.F. (2011) The amazing osteocyte. Journal of Bone and Mineral Research 26: 229-238
3. Buddecke, D.E.. Jr, Lile, L.N. & Barp, E.A. (2001) Bone grafting. Principles and applications in the lower extremity. Clinics in podiatric medicine and surgery 18: 109-145 vi
4. Buser, D., Bornstein, M.M., Weber, H.P., Grutter, L., Schmid, B. & Belser, U.C. (2008) Early implant placement with simultaneous guided bone regeneration following single-tooth extraction in the esthetic zone: a cross-sectional, retrospective study in 45 subjects with a 2- to 4-year follow-up. Journal of Periodontology 79: 1773-1781
5. Chiapasco, M., Casentini, P. & Zaniboni, M. (2009) Bone augmentation procedures in implant dentistry. International Journal of Oral & Maxillofacial Implants 24(Suppl): 237-259
6. Dallas, S.L., Prideaux, M. & Bonewald, L.F. (2013) The osteocyte: an endocrine cell and more. Endocrine Reviews 34: 658-690
7. Fulzele, K., Krause, D.S., Panaroni, C., Saini, V., Barry, K.J., Liu, X., Lotinun, S., Baron, R., Bonewald, L., Feng, J.Q., Chen, M., Weinstein, L.S., Wu, J.Y., Kronenberg, H.M., Scadden, D.T. & Divieti Pajevic, P. (2013) Myelopoiesis is regulated by osteocytes through gsalpha-dependent signaling. Blood 121: 930-939
8. Gruskin, E., Doll, B.A., Futrell, F.W., Schmitz, J.P. & Hollinger, J.O. (2012) Demineralized bone matrix in bone repair: history and use. Advanced Drug Delivery Reviews 64: 1063-1077
9. Jager, A., Gotz, W., Lossdorfer, S. & Rath-Deschner, B. (2010) Localization of sost/sclerostin in cementocytes in vivo and in mineralizing periodontal ligament cells in vitro. Journal of Periodontal Research 45: 246-254
10. Jensen, S.S., Broggini, N., Hjorting-Hansen, E., Schenk, R. & Buser, D. (2006) Bone healing and graft resorption of autograft, anorganic bovine bone and beta-tricalcium phosphate. A histologic and histomorphometric study in the mandibles of minipigs. Clinical Oral Implants Research 17: 237-243
11. Juppner, H. (2011) Phosphate and fgf-23. Kidney International Supplements Apr: S24-S27
12. Kim, Y.K., Kim, S.G., Lim, S.C., Lee, H.J. & Yun, P.Y. (2010) A clinical study on bone formation using a demineralized bone matrix and resorbable membrane. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 109: e6-e11
13. Kolar, P., Schmidt-Bleek, K., Schell, H., Gaber, T., Toben, D., Schmidmaier, G., Perka, C., Buttgereit, F. & Duda, G.N. (2010) The early fracture hematoma and its potential role in fracture healing. Tissue Engineering. Part B. Reviews 16: 427-434
14. Manolagas, S.C. & Parfitt, A.M. (2013) For whom the bell tolls: distress signals from long-lived osteocytes and the pathogenesis of metabolic bone diseases. Bone 54: 272-278
15. Miron, R.J., Gruber, R., Hedbom, E., Saulacic, N., Zhang, Y., Sculean, A., Bosshardt, D.D. & Buser, D. (2012) Impact of bone harvesting techniques on cell viability and the release of growth factors of autografts. Clinical Implant Dentistry and Related Research 15: 481-489
16. Myeroff, C. & Archdeacon, M. (2011) Autogenous bone graft: donor sites and techniques. The Journal of Bone and Joint Surgery. American Volume 93: 2227-2236
17. Peng, J., Nemec, M., Brolese, E., Bosshardt, D.D., Schaller, B., Buser, D. & Gruber, R. (2014) Bone-conditioned medium inhibits osteogenic and adipogenic differentiation of mesenchymal cells in vitro. Clinical Implant Dentistry and Related Research. [Epub ahead of print]
18. Pereira, R.C., Juppner, H., Azucena-Serrano, C.E., Yadin, O., Salusky, I.B. & Wesseling-Perry, K. (2009) Patterns of fgf-23, dmp1, and mepe expression in patients with chronic kidney disease. Bone 45: 1161-1168
19. Quarles, L.D. (2012) Skeletal secretion of fgf-23 regulates phosphate and vitamin d metabolism. Nature Reviews. Endocrinology 8: 276-286
20. Rogers, G.F. & Greene, A.K. (2012) Autogenous bone graft: basic science and clinical implications. The Journal of Craniofacial Surgery 23: 323-327
21. Saulacic, N., Bosshardt, D.D., Jensen, S.S., Miron, R.J., Gruber, R. & Buser, D. (2014) Impact of bone graft harvesting techniques on bone formation and graft resorption: a histomorphometric study in the mandibles of minipigs. Clinical Oral Implants Research 26: 383-391
22. Schindeler, A., McDonald, M.M., Bokko, P. & Little, D.G. (2008) Bone remodeling during fracture repair: the cellular picture. Seminars in Cell and Developmental Biology 19: 459-466
23. Tessier, P. (1982) Autogenous bone grafts taken from the calvarium for facial and cranial applications. Clinics in Plastic Surgery 9: 531-538
24. Yoshiko, Y., Wang, H., Minamizaki, T., Ijuin, C., Yamamoto, R., Suemune, S., Kozai, K., Tanne, K., Aubin, J.E. & Maeda, N. (2007) Mineralized tissue cells are a principal source of fgf23. Bone 40: 1565-1573